STOCK TITAN

Innovative Eyewear Inc (LUCY) director details recent common stock trades

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Innovative Eyewear Inc director Vladimir Galkin reported two transactions in the company’s common stock. On 12/10/2025, a transaction labeled code 'P' involved 50,300 shares at $1.49 per share, leaving 947,193 shares beneficially owned directly afterward. On 12/11/2025, another code 'P' transaction covered 8,423 shares at $1.58 per share, with 938,770 shares beneficially owned directly afterward. The filing notes these common shares are held jointly by Vladimir and Angelica Galkin, husband and wife.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Galkin Vladimir

(Last) (First) (Middle)
10900 N.W. 97TH. STREET, SUITE #102

(Street)
MIAMI FL 33178

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.00001 12/10/2025 P 50,300 D $1.49 947,193 D(1)
Common Stock, par value $0.00001 12/11/2025 P 8,423 D $1.58 938,770 D(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The shares of Common Stock are held jointly by Vladimir Galkin and Angelica Galkin, husband and wife.
Vladimir Galkin, Attorney in Fact 12/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Innovative Eyewear Inc (LUCY) disclose?

Innovative Eyewear Inc (LUCY) disclosed that director Vladimir Galkin reported two transactions in the company’s common stock on 12/10/2025 and 12/11/2025, both labeled with transaction code 'P'.

How many Innovative Eyewear (LUCY) shares were involved in Vladimir Galkin’s recent transactions?

The filing shows one transaction involving 50,300 common shares on 12/10/2025 and a second transaction involving 8,423 common shares on 12/11/2025.

At what prices were the reported Innovative Eyewear (LUCY) share transactions executed?

The 12/10/2025 transaction was reported at a price of $1.49 per share, and the 12/11/2025 transaction was reported at $1.58 per share.

How many Innovative Eyewear (LUCY) shares does Vladimir Galkin beneficially own after these transactions?

After the 12/10/2025 transaction, Vladimir Galkin beneficially owned 947,193 common shares. After the 12/11/2025 transaction, his beneficial ownership was reported as 938,770 common shares, held directly.

How are the reported Innovative Eyewear (LUCY) shares held by Vladimir and Angelica Galkin?

The filing explains that the reported common shares are held jointly by Vladimir Galkin and Angelica Galkin, who are husband and wife.

What is Vladimir Galkin’s relationship to Innovative Eyewear Inc (LUCY)?

The report identifies Vladimir Galkin as a director of Innovative Eyewear Inc, filing the form as one reporting person.

Lucyd Inc

NASDAQ:LUCY

LUCY Rankings

LUCY Latest News

LUCY Latest SEC Filings

LUCY Stock Data

7.49M
4.12M
34.15%
4.12%
3.29%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MIAMI